Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $10,000 dinners and fishing trips for doctors, signs pointed to the Swiss drugmaker finally having its day in court. Now it looks like that may not happen. Novartis could be approaching a billion-dollar settlement with the U.S. government as part of a whistleblower lawsuit accusing the company of bribing doctors to boost subscriptions of its drugs, sources told STAT. https://www.fiercepharma.com/pharma/novartis-could-settle-for-1b-as-part-federal-kickback-lawuit-stat
